Pulmonology · Medical Literature
[Articles] Diversity analysis of indoor and outdoor fungal bioaerosols in UK households: a prospective, observational, longitudinal study
Abstract
Indoor fungal bioaerosols are more diverse and dynamic than outdoor communities in urban UK homes. These findings establish foundational exposure data and highlight the need for incorporating fungal bioaerosol monitoring into public health policy to mitigate mould-related health risks.
Clinical relevance
In urban UK households, how do the diversity, composition, and seasonal dynamics of indoor fungal bioaerosol communities compare with those of concurrently sampled outdoor air, and what does this imply for baseline exposure characterization and public health policy? __SNAPSHOT__ {"studyDesign":"Prospective, community-based observational longitudinal study (the WellHome Study)","setting":"118 residential households across West London, UK, with outdoor reference samples collected at four fixed community garden sites within the same catchment area; conducted between October 3, 2022, and June 14, 2024","sampleSize":"n = 118 households comprising 504 residents (263 women, 237 men, 4 not reported); 262 total air samples (indoor and outdoor combined)","population":"Urban West London residents recruited via community networks and partner organisations, with deliberate enrichment for ethnically and socioeconomically diverse households, children with asthma or allergies, and families from ethnic minority and lower socioeconomic backgrounds","intervention":"Passive air sampling with ITS2 amplicon sequencing (metabarcoding) and quantitative PCR (qPCR) to characterise indoor fungal bioaerosol diversity, composition, and absolute abundance across seasons","comparator":"Concurrently collected outdoor air samples from four fixed community garden reference sites within the same geographic catchment","primaryOutcome":"Diversity (richness and evenness) and composition of indoor versus outdoor fungal bioaerosol communities, including identification of genera enriched indoors, characterised across sampling timepoints using diversity indices and generalised additive models","followUp":"Approximately 20 months (October 2022 – June 2024), with sampling distributed across seasons to ensure temporal coverage","fundingSource":"Not reported in available abstract; study is affiliated with Imperial College London (government/academic institution); specific grant sources not confirmed from available sources"}
Key findings
Across 262 indoor and outdoor air samples collected from 118 West London households, investigators identified more than 2,000 fungal genera. Indoor fungal communities were significantly richer, more diverse, and more variable between locations than communities detected at outdoor reference sites. Indoor communities also demonstrated stronger seasonal cycling than outdoor communities, indicating that residential environments function as distinct, dynamic fungal ecosystems rather than passive recipients of ambient outdoor air. Several medically relevant genera — including Aspergillus, Penicillium, and Wallemia — were consistently enriched indoors relative to outdoor air. Visible mould was associated with some of the highest total fungal burdens measured in the study; however, clinically significant levels of airborne fungi were also detected in homes with no visible mould or damp. In one index case, persistently elevated Aspergillus levels were documented in the absence of visible mould in a home where a child with confirmed Aspergillus allergy experienced repeated asthma-related hospitalisations during the study period. Specific p-values, confidence intervals, effect sizes, and NNT/NNH were not reported in the available abstract or press materials; all quantitative comparisons described above are from abstract-level or press-release summaries only.
Practice implications
This study establishes, for the first time at large scale in a UK urban population, that indoor residential air is a distinctly richer and more diverse fungal environment than outdoor air, and that this disparity is driven by indoor-specific factors (building materials, furnishings, moisture, and occupant activity) rather than simply by infiltration of outdoor fungal communities. The enrichment of clinically relevant genera — Aspergillus, Penicillium, and Wallemia — indoors has direct pulmonological relevance, as these taxa are established triggers of fungal sensitisation, allergic bronchopulmonary aspergillosis, severe asthma with fungal sensitisation (SAFS), and hypersensitivity pneumonitis. The sentinel case of a child with uncontrolled asthma, confirmed Aspergillus allergy, and repeated hospitalisations in a home lacking visible mould highlights a critical clinical gap: current standard-of-care housing assessment based on visual inspection and culture of a limited species panel is insufficient to characterise the true airborne fungal burden. Findings apply most directly to urban UK households and the populations studied (children with asthma/allergy, ethnic minority families, lower socioeconomic groups); generalisability to rural UK settings, non-UK housing stock, or immunocompromised populations warrants separate study. Because this is an observational, descriptive exposure study, no causal relationship between indoor fungal bioaerosol burden and respiratory health outcomes was established — the study was not powered or designed to test clinical endpoints. Notably, only an abstract and press summaries were available for this review; full quantitative data, regression outputs, and subgroup analyses could not be independently verified. Practice should not change on the basis of this study alone, but findings provide a strong evidence foundation to advocate for quantitative bioaerosol monitoring standards in clinical and regulatory contexts. __LIMITATIONS__ Observational design precludes causal inference between indoor fungal bioaerosol exposure and respiratory health outcomes.,Geographically restricted to West London; findings may not generalise to rural UK environments, other UK housing types, or international settings.,Only abstract-level data were available for this structured review; specific effect sizes, p-values, and confidence intervals could not be verified.,Passive air samplers and DNA-based sequencing (ITS2 metabarcoding) detect fungal genetic material, including non-viable spores; clinical relevance of individual genera detected by sequencing versus viable, culturable organisms is uncertain.,The study is primarily a descriptive exposure characterisation study, not designed or powered to test health outcomes; the single index case linking Aspergillus burden to childhood asthma hospitalisations is anecdotal and cannot establish causation.,The outdoor comparator comprised only four fixed community garden sites, which may not fully represent the heterogeneity of outdoor urban air across the study catchment.,Recruitment through community networks and partner organisations, though designed to improve diversity, may introduce selection bias if participating households differ systematically from non-participating households in housing quality or health status.,No universally accepted health-based numerical thresholds for indoor fungal bioaerosols currently exist, limiting the immediate clinical interpretability of the quantitative abundance data generated.,Funding source and potential conflicts of interest were not reported in available sources. __BOTTOM_LINE_CATEGORY__ promising_but_preliminary __BOTTOM_LINE__ This largest UK longitudinal study of indoor fungal bioaerosols demonstrates that residential indoor air is a uniquely diverse and dynamic fungal ecosystem, with clinically relevant genera such as Aspergillus, Penicillium, and Wallemia consistently enriched indoors relative to outdoor air — and that this burden cannot be reliably detected by visual inspection alone. While the observational design precludes causal inference with respiratory health outcomes, the findings provide essential baseline exposure data and a compelling evidence base for the development of quantitative indoor fungal bioaerosol standards in housing and public health policy. Pulmonologists managing patients with asthma, allergic fungal disease, or SAFS in suboptimal housing should be aware that the absence of visible mould does not exclude clinically significant indoor fungal bioaerosol exposure.